Jeffrey B. VanDeusen, Ph.D.

Affiliations: 
2004 Ohio State University, Columbus, Columbus, OH 
Area:
Immunology
Google:
"Jeffrey VanDeusen"

Parents

Sign in to add mentor
Michael A. Caligiuri grad student 2004 Ohio State
 (A role for STAT-1 in regulating interleukin 10 production following LPS challenge.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wing MR, Reeser JW, Smith AM, et al. (2017) Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancer. Oncotarget. 8: 75822-75833
Guimond M, Freud AG, Mao HC, et al. (2010) In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. Journal of Immunology (Baltimore, Md. : 1950). 184: 2769-75
Yokohama A, Mishra A, Mitsui T, et al. (2010) A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia. Leukemia Research. 34: 203-9
VanDeusen JB, Shah MH, Becknell B, et al. (2006) STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo. European Journal of Immunology. 36: 623-30
VanDeusen JB, Caligiuri MA. (2003) New developments in anti-tumor efficacy and malignant transformation of human natural killer cells. Current Opinion in Hematology. 10: 55-9
Cooper MA, Bush JE, Fehniger TA, et al. (2002) In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood. 100: 3633-8
Fehniger TA, Suzuki K, VanDeusen JB, et al. (2001) Fatal leukemia in interleukin-15 transgenic mice. Blood Cells, Molecules & Diseases. 27: 223-30
Fehniger TA, Suzuki K, Ponnappan A, et al. (2001) Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. The Journal of Experimental Medicine. 193: 219-31
Fehniger TA, Bluman EM, Porter MM, et al. (2000) Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. The Journal of Clinical Investigation. 106: 117-24
Fehniger TA, Shah MH, Turner MJ, et al. (1999) Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. Journal of Immunology (Baltimore, Md. : 1950). 162: 4511-20
See more...